Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19.

Acharya A, Berry DC, Zhang H, Jiang Y, Jones BT, Hammer RE, Graff JM, Mendell JT.

Genes Dev. 2019 Sep 5. doi: 10.1101/gad.328955.119. [Epub ahead of print]

PMID:
31488578
2.

PUMILIO, but not RBMX, binding is required for regulation of genomic stability by noncoding RNA NORAD.

Elguindy MM, Kopp F, Goodarzi M, Rehfeld F, Thomas A, Chang TC, Mendell JT.

Elife. 2019 Jul 25;8. pii: e48625. doi: 10.7554/eLife.48625.

3.

Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, Sood AK, Mendell JT, Wan Y.

Nature. 2019 Jun;570(7761):E51. doi: 10.1038/s41586-019-1266-4.

PMID:
31127195
4.

MIR205HG Is a Long Noncoding RNA that Regulates Growth Hormone and Prolactin Production in the Anterior Pituitary.

Du Q, Hoover AR, Dozmorov I, Raj P, Khan S, Molina E, Chang TC, de la Morena MT, Cleaver OB, Mendell JT, van Oers NSC.

Dev Cell. 2019 May 20;49(4):618-631.e5. doi: 10.1016/j.devcel.2019.03.012. Epub 2019 Apr 11.

PMID:
30982661
5.

PUMILIO hyperactivity drives premature aging of Norad-deficient mice.

Kopp F, Elguindy MM, Yalvac ME, Zhang H, Chen B, Gillett FA, Lee S, Sivakumar S, Yu H, Xie Y, Mishra P, Sahenk Z, Mendell JT.

Elife. 2019 Feb 8;8. pii: e42650. doi: 10.7554/eLife.42650.

6.

Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1.

Chen KS, Stroup EK, Budhipramono A, Rakheja D, Nichols-Vinueza D, Xu L, Stuart SH, Shukla AA, Fraire C, Mendell JT, Amatruda JF.

Genes Dev. 2018 Aug 1;32(15-16):996-1007. doi: 10.1101/gad.313783.118. Epub 2018 Jul 19.

7.

High-Throughput Characterization of Primary microRNA Transcripts.

Chang TC, Mendell JT.

Methods Mol Biol. 2018;1823:1-9. doi: 10.1007/978-1-4939-8624-8_1.

PMID:
29959669
8.

Loss of Dis3l2 partially phenocopies Perlman syndrome in mice and results in up-regulation of Igf2 in nephron progenitor cells.

Hunter RW, Liu Y, Manjunath H, Acharya A, Jones BT, Zhang H, Chen B, Ramalingam H, Hammer RE, Xie Y, Richardson JA, Rakheja D, Carroll TJ, Mendell JT.

Genes Dev. 2018 Jul 1;32(13-14):903-908. doi: 10.1101/gad.315804.118. Epub 2018 Jun 27.

9.

Functional Classification and Experimental Dissection of Long Noncoding RNAs.

Kopp F, Mendell JT.

Cell. 2018 Jan 25;172(3):393-407. doi: 10.1016/j.cell.2018.01.011. Review.

10.

Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice.

Quirin KA, Kwon JJ, Alioufi A, Factora T, Temm CJ, Jacobsen M, Sandusky GE, Shontz K, Chicoine LG, Clark KR, Mendell JT, Korc M, Kota J.

Mol Ther Methods Clin Dev. 2017 Sep 30;8:8-20. doi: 10.1016/j.omtm.2017.09.006. eCollection 2018 Mar 16.

11.

Erratum: Publisher Correction: Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.

Rakheja D, Chen KS, Liu Y, Shukla AA, Schmid V, Chang TC, Khokhar S, Wickiser JE, Karandikar NJ, Malter JS, Mendell JT, Amatruda JF.

Nat Commun. 2017 Nov 29;8:16177. doi: 10.1038/ncomms16177. eCollection 2017.

12.

MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin.

Heller KN, Mendell JT, Mendell JR, Rodino-Klapac LR.

JCI Insight. 2017 May 4;2(9). pii: 93309. doi: 10.1172/jci.insight.93309. eCollection 2017 May 4.

13.

An Argonaute phosphorylation cycle promotes microRNA-mediated silencing.

Golden RJ, Chen B, Li T, Braun J, Manjunath H, Chen X, Wu J, Schmid V, Chang TC, Kopp F, Ramirez-Martinez A, Tagliabracci VS, Chen ZJ, Xie Y, Mendell JT.

Nature. 2017 Feb 9;542(7640):197-202. doi: 10.1038/nature21025. Epub 2017 Jan 23.

14.

Targeting a Long Noncoding RNA in Breast Cancer.

Mendell JT.

N Engl J Med. 2016 Jun 9;374(23):2287-9. doi: 10.1056/NEJMcibr1603785. No abstract available.

PMID:
27276568
15.

Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1.

Kent OA, Mendell JT, Rottapel R.

Mol Cancer Res. 2016 Mar;14(3):267-77. doi: 10.1158/1541-7786.MCR-15-0456. Epub 2016 Jan 8.

16.

Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins.

Lee S, Kopp F, Chang TC, Sataluri A, Chen B, Sivakumar S, Yu H, Xie Y, Mendell JT.

Cell. 2016 Jan 14;164(1-2):69-80. doi: 10.1016/j.cell.2015.12.017. Epub 2015 Dec 24.

17.

Precise let-7 expression levels balance organ regeneration against tumor suppression.

Wu L, Nguyen LH, Zhou K, de Soysa TY, Li L, Miller JB, Tian J, Locker J, Zhang S, Shinoda G, Seligson MT, Zeitels LR, Acharya A, Wang SC, Mendell JT, He X, Nishino J, Morrison SJ, Siegwart DJ, Daley GQ, Shyh-Chang N, Zhu H.

Elife. 2015 Oct 7;4:e09431. doi: 10.7554/eLife.09431.

18.

Genome-wide annotation of microRNA primary transcript structures reveals novel regulatory mechanisms.

Chang TC, Pertea M, Lee S, Salzberg SL, Mendell JT.

Genome Res. 2015 Sep;25(9):1401-9. doi: 10.1101/gr.193607.115.

19.

Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.

Knabel MK, Ramachandran K, Karhadkar S, Hwang HW, Creamer TJ, Chivukula RR, Sheikh F, Clark KR, Torbenson M, Montgomery RA, Cameron AM, Mendell JT, Warren DS.

PLoS One. 2015 Apr 29;10(4):e0124411. doi: 10.1371/journal.pone.0124411. eCollection 2015.

20.

StringTie enables improved reconstruction of a transcriptome from RNA-seq reads.

Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL.

Nat Biotechnol. 2015 Mar;33(3):290-5. doi: 10.1038/nbt.3122. Epub 2015 Feb 18.

21.

Seeing through the miRage of tissue complexity.

Shi G, Mendell JT.

Cell Cycle. 2014;13(19):2988-9. doi: 10.4161/15384101.2014.962852. No abstract available.

22.

Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis.

Zeitels LR, Acharya A, Shi G, Chivukula D, Chivukula RR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, Richardson JA, Mendell JT.

Genes Dev. 2014 Dec 1;28(23):2585-90. doi: 10.1101/gad.250951.114. Epub 2014 Nov 13.

23.

Identification of miR-145 targets through an integrated omics analysis.

Huang TC, Renuse S, Pinto S, Kumar P, Yang Y, Chaerkady R, Godsey B, Mendell JT, Halushka MK, Civin CI, Marchionni L, Pandey A.

Mol Biosyst. 2015 Jan;11(1):197-207. doi: 10.1039/c4mb00585f. Epub 2014 Oct 30.

24.

Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.

Rakheja D, Chen KS, Liu Y, Shukla AA, Schmid V, Chang TC, Khokhar S, Wickiser JE, Karandikar NJ, Malter JS, Mendell JT, Amatruda JF.

Nat Commun. 2014 Sep 5;2:4802. doi: 10.1038/ncomms5802. Erratum in: Nat Commun. 2017 Nov 29;8:16177.

25.

miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, Sood AK, Mendell JT, Wan Y.

Nature. 2014 Aug 28;512(7515):431-5. doi: 10.1038/nature13375. Epub 2014 Jun 25. Erratum in: Nature. 2019 Jun;570(7761):E51.

26.

An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration.

Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, Maitra A, Mendell JT.

Cell. 2014 May 22;157(5):1104-16. doi: 10.1016/j.cell.2014.03.055.

27.

PIPE-CLIP: a comprehensive online tool for CLIP-seq data analysis.

Chen B, Yun J, Kim MS, Mendell JT, Xie Y.

Genome Biol. 2014 Jan 22;15(1):R18. doi: 10.1186/gb-2014-15-1-r18.

28.

When 19 is greater than 92.

Zeitels LR, Mendell JT.

Elife. 2013 Oct 15;2:e01514. doi: 10.7554/eLife.01514.

29.

Noncoding RNAs and cancer.

Lieberman J, Slack F, Pandolfi PP, Chinnaiyan A, Agami R, Mendell JT.

Cell. 2013 Mar 28;153(1):9-10. No abstract available.

30.

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K.

J Clin Invest. 2012 Aug;122(8):2871-83. doi: 10.1172/JCI63539. Epub 2012 Jul 23.

31.

A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts.

Ribas J, Ni X, Castanares M, Liu MM, Esopi D, Yegnasubramanian S, Rodriguez R, Mendell JT, Lupold SE.

Nucleic Acids Res. 2012 Aug;40(14):6821-33. doi: 10.1093/nar/gks308. Epub 2012 Apr 13.

32.

MicroRNAs in stress signaling and human disease.

Mendell JT, Olson EN.

Cell. 2012 Mar 16;148(6):1172-87. doi: 10.1016/j.cell.2012.02.005. Review.

33.

Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis.

Chaulk SG, Thede GL, Kent OA, Xu Z, Gesner EM, Veldhoen RA, Khanna SK, Goping IS, MacMillan AM, Mendell JT, Young HS, Fahlman RP, Glover JN.

RNA Biol. 2011 Nov-Dec;8(6):1105-14. doi: 10.4161/rna.8.6.17410. Epub 2011 Nov 1.

PMID:
21955497
34.

Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.

Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, Mendell JT, Maitra A.

Mol Cancer Ther. 2011 Aug;10(8):1470-80. doi: 10.1158/1535-7163.MCT-11-0152. Epub 2011 May 27.

35.

KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.

Lee YN, Brandal S, Noel P, Wentzel E, Mendell JT, McDevitt MA, Kapur R, Carter M, Metcalfe DD, Takemoto CM.

Blood. 2011 Mar 31;117(13):3629-40. doi: 10.1182/blood-2010-07-293548. Epub 2011 Jan 27.

36.

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.

Kent OA, Chivukula RR, Mullendore M, Wentzel EA, Feldmann G, Lee KH, Liu S, Leach SD, Maitra A, Mendell JT.

Genes Dev. 2010 Dec 15;24(24):2754-9. doi: 10.1101/gad.1950610.

37.

Quantification of global microRNA abundance by selective isotachophoresis.

Persat A, Chivukula RR, Mendell JT, Santiago JG.

Anal Chem. 2010 Dec 1;82(23):9631-5. doi: 10.1021/ac102496m. Epub 2010 Nov 9.

PMID:
21062022
38.

Myc: Maestro of MicroRNAs.

Bui TV, Mendell JT.

Genes Cancer. 2010 Jun 1;1(6):568-575.

39.

Identifying targets of miR-143 using a SILAC-based proteomic approach.

Yang Y, Chaerkady R, Kandasamy K, Huang TC, Selvan LD, Dwivedi SB, Kent OA, Mendell JT, Pandey A.

Mol Biosyst. 2010 Oct;6(10):1873-82. doi: 10.1039/c004401f. Epub 2010 Jun 14.

40.

P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis.

Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, Huso D, Lowenstein CJ.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9. doi: 10.1073/pnas.0911082107. Epub 2010 Mar 22.

41.

A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.

Kent OA, Mullendore M, Wentzel EA, López-Romero P, Tan AC, Alvarez H, West K, Ochs MF, Hidalgo M, Arking DE, Maitra A, Mendell JT.

Cancer Biol Ther. 2009 Nov;8(21):2013-24.

42.

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.

Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R, Mendell JT, Lupold SE.

Cancer Res. 2009 Sep 15;69(18):7165-9. doi: 10.1158/0008-5472.CAN-09-1448. Epub 2009 Sep 8.

43.

Tumors line up for a letdown.

Mendell JT.

Nat Genet. 2009 Jul;41(7):768-9. doi: 10.1038/ng0709-768.

PMID:
19557079
44.

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT.

Cell. 2009 Jun 12;137(6):1005-17. doi: 10.1016/j.cell.2009.04.021.

45.

Abate and switch: miR-145 in stem cell differentiation.

Chivukula RR, Mendell JT.

Cell. 2009 May 15;137(4):606-8. doi: 10.1016/j.cell.2009.04.059.

46.

Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.

Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, Maitra A.

Pancreatology. 2009;9(3):293-301. doi: 10.1159/000186051. Epub 2009 Apr 29.

47.

Cell-cell contact globally activates microRNA biogenesis.

Hwang HW, Wentzel EA, Mendell JT.

Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7016-21. doi: 10.1073/pnas.0811523106. Epub 2009 Apr 9.

48.

Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach.

Yang Y, Chaerkady R, Beer MA, Mendell JT, Pandey A.

Proteomics. 2009 Mar;9(5):1374-84. doi: 10.1002/pmic.200800551.

49.

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV.

Nature. 2009 Apr 9;458(7239):762-5. doi: 10.1038/nature07823. Epub 2009 Feb 15.

50.

Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.

Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, Thomas-Tikhonenko A, Mendell JT.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3384-9. doi: 10.1073/pnas.0808300106. Epub 2009 Feb 11.

Supplemental Content

Loading ...
Support Center